Hikikomori : Multidimensional understanding, assessment, and future international perspectives
Hikikomori, a severe form of social withdrawal, has long been observed in Japan mainly
among youth and adolescents since around the 1970s, and has been especially highlighted …
among youth and adolescents since around the 1970s, and has been especially highlighted …
The role and mechanism of tryptophan–kynurenine metabolic pathway in depression
X Gong, R Chang, J Zou, S Tan… - Reviews in the …, 2023 - degruyter.com
Major depressive disorder (MDD) is a common mental illness characterized by persistent
low mood and anhedonia, normally accompanied with cognitive impairment. Due to its rising …
low mood and anhedonia, normally accompanied with cognitive impairment. Due to its rising …
The kynurenine pathway in major depressive disorder, bipolar disorder, and schizophrenia: a meta-analysis of 101 studies
The importance of tryptophan as a precursor for neuroactive compounds has long been
acknowledged. The metabolism of tryptophan along the kynurenine pathway and its …
acknowledged. The metabolism of tryptophan along the kynurenine pathway and its …
The role of bacteria and its derived metabolites in chronic pain and depression: recent findings and research progress
S Li, D Hua, Q Wang, L Yang, X Wang… - International Journal …, 2020 - academic.oup.com
Background Chronic pain is frequently comorbid with depression in clinical practice.
Recently, alterations in gut microbiota and metabolites derived therefrom have been found …
Recently, alterations in gut microbiota and metabolites derived therefrom have been found …
[HTML][HTML] The tryptophan catabolite or kynurenine pathway in major depressive and bipolar disorder: A systematic review and meta-analysis
AF Almulla, Y Thipakorn, A Vasupanrajit… - Brain, behavior, & …, 2022 - Elsevier
Background There is now evidence that affective disorders including major depressive
disorder (MDD) and bipolar disorder (BD) are mediated by immune-inflammatory and nitro …
disorder (MDD) and bipolar disorder (BD) are mediated by immune-inflammatory and nitro …
[HTML][HTML] Kynurenic acid is a potential overlapped biomarker between diagnosis and treatment response for depression from metabolome analysis
H Erabi, G Okada, C Shibasaki, D Setoyama, D Kang… - Scientific reports, 2020 - nature.com
Since optimal treatment at an early stage leads to remission of symptoms and recovery of
function, putative biomarkers leading to early diagnosis and prediction of therapeutic …
function, putative biomarkers leading to early diagnosis and prediction of therapeutic …
[HTML][HTML] Suicide and microglia: recent findings and future perspectives based on human studies
H Suzuki, M Ohgidani, N Kuwano, F Chrétien… - Frontiers in cellular …, 2019 - frontiersin.org
Suicide is one of the most disastrous outcomes for psychiatric disorders. Recent advances in
biological psychiatry have suggested a positive relationship between some specific brain …
biological psychiatry have suggested a positive relationship between some specific brain …
Cholesterol and triglyceride levels in first-episode patients with major depressive disorder: A meta-analysis of case-control studies
YG Wei, DB Cai, J Liu, RX Liu, SB Wang… - Journal of Affective …, 2020 - Elsevier
Background: Lipid profile disturbances are frequently observed in major depressive disorder
(MDD) and constitute to high mortality rates. However, less is known about whether this risk …
(MDD) and constitute to high mortality rates. However, less is known about whether this risk …
Increasing carbohydrate availability in the hindgut promotes hypothalamic neurotransmitter synthesis: aromatic amino acids linking the microbiota–brain axis
The gut microbiota is increasingly recognized to modulate brain function by recent studies
demonstrating the central effects of various gut microbial manipulation strategies. Our …
demonstrating the central effects of various gut microbial manipulation strategies. Our …
[HTML][HTML] Kynurenine pathway metabolites as biomarkers for amyotrophic lateral sclerosis
VX Tan, GJ Guillemin - Frontiers in Neuroscience, 2019 - frontiersin.org
Amyotrophic Lateral Sclerosis (ALS) currently lacks a robust and well-defined biomarker that
can 1) assess the progression of the disease, 2) predict and/or delineate the various clinical …
can 1) assess the progression of the disease, 2) predict and/or delineate the various clinical …